<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        15-237-97
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1997
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VINBLASTINE SULPHATE 10MG-10ML VIAL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        VINCRISTINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        223.75
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="HOSPIRA AUSTRALIA " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            HOSPIRA AUSTRALIA 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2657]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Pfizer Saudi Trading
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            HOSPIRA AUSTRALIA 
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L01CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Vinblastine sulphate is an anti-cancer medicine. Treatment with an anti-cancer medicine is sometimes called cancer chemotherapy.</p><p>&nbsp;</p><p>Vinblastine Sulphate Injection is sometimes used in the treatment of cancers of the lymph nodes, spleen, bone marrow, testicles, placenta, kidney and breast.&nbsp; It may be given alone or in combination with other anti-cancer medicines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Vinblastine Sulphate Injection must never be injected intrathecally (into the spine).</strong></p><p><strong>&nbsp;</strong></p><p><strong>Do not use Vinblastine Sulphate Injection:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to vinblastine or to any of the other ingredients of this medicine (listed in section 6).</p><ul><li>if you have a bacterial infection which is not under control</li><li>if your blood tests show that you do not have enough white blood cells to fight infection</li></ul><p>&nbsp;</p><p>Tell your doctor if any of the above applies to you before this medicine is used.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or nurse before using Vinblastine Sulphate Injection</p><ul><li>if you are an elderly patient in poor health or with skin sores</li><li>if you have liver disease, including inflammation of the liver (hepatitis) or yellowing of your skin or the whites of your eyes (jaundice).</li></ul><p>&nbsp;</p><p>If you notice any of the following, and they do not go away, this might also mean that you have liver problems:</p><p>&bull; Loss of appetite.</p><p>&bull; Feeling itchy.</p><p>&bull; Feeling tired, having no energy or feeling like you have flu.</p><p>&bull; Feeling as though you are going to be sick or actually being sick.</p><p>&nbsp;</p><p>If in doubt, check with your doctor.</p><p>&nbsp;</p><p>Tell your doctor if any of the above apply to you, before this medicine is used.</p><p>&nbsp;</p><p><strong>Other medicines and Vinblastine Sulphate Injection</strong></p><p>Special care is needed if you are taking/using other medicines as some could interact with vinblastine sulphate, for example:</p><ul><li>the use of mitomycin-C and/or progesterone (anti-cancer medicines), with vinblastine may cause breathing problems</li><li>the use of bleomycin or cisplatin (anti-cancer medicines) with vinblastine may cause heart and circulation problems (e.g. Raynaud&rsquo;s phenomenon)</li><li>the use of erythromycin (antibiotic) may increase the side effects of vinblastine</li><li>vinblastine may reduce the effectiveness of medicines used to treat epilepsy</li><li>if you are having radiotherapy in the liver area your doctor will delay giving you vinblastine</li></ul><p>&nbsp;</p><p>Tell your doctor if you are taking, have recently taken or might take any other medicines.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p><strong>&nbsp;</strong></p><p>Tell your doctor if you are pregnant, trying to become pregnant or breast-feeding. Your doctor will decide if you should receive this medicine.</p><p>&nbsp;</p><p>As there is a risk of birth defects, women of childbearing potential should use appropriate contraception methods during treatment with vinblastine sulphate.</p><p><strong>&nbsp;</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong></p><p>Do not drive or use machines if you experience any side effect which may lessen your ability to do so.</p><p><strong>&nbsp;</strong></p><p><strong>Vinblastine Sulphate Injection contains sodium</strong></p><p>This medicinal product contains 1.5 mmol sodium (35 mg) per vial. To be taken into consideration by patients on a controlled sodium diet.</p><p>&nbsp;</p><p>The vial stopper contains dry natural rubber (a derivative of latex), which may cause allergic reactions.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine is given by injection (using a syringe) into a vein.&nbsp; Alternatively, it may be injected into the line of a running infusion (drip).</p><p>&nbsp;</p><p>Vinblastine sulphate is an irritant, if it accidentally gets into your eyes tell your doctor or nurse immediately so that it may be washed out.</p><p>&nbsp;</p><p>You may be given medicines to prevent nausea and vomiting during treatment with vinblastine sulphate.</p><p>&nbsp;</p><p><strong>Dosage</strong></p><p>Your doctor will work out the correct dose of vinblastine sulphate for you and how often it must be given.&nbsp;</p><p>&nbsp;</p><p>The dose will depend on your medical condition, your size and how well your liver is working. Your doctor will tell how well your liver is working using a blood sample.&nbsp; If your liver is not working properly the dose may be reduced.</p><p>&nbsp;</p><p>Vinblastine sulphate is usually given once a week or less.</p><p>&nbsp;</p><p><strong>If you are given too much or too little Vinblastine Sulphate Injection</strong></p><p>This medicine will be given to you in a hospital, under the supervision of a doctor.&nbsp; It is unlikely that you will be given too much or too little, however, tell your doctor or nurse if you have any concerns.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can have side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>If any of the following happen, tell your doctor immediately:</strong></p><ul><li>severe allergic reaction &ndash; you may experience a sudden itchy rash (hives), swelling of the hands, feet, ankles, face, lips, mouth or throat (which may cause difficulty in swallowing or breathing), and you may feel you are going to faint.</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain or swelling at the injection site during or immediately after the injection</p><p>&nbsp;</p><p>These are serious side effects. You may need urgent medical attention.</p><p>&nbsp;</p><p><strong>If any of the following happen, tell your doctor as soon as possible:</strong></p><ul><li>low blood cell count which may be present as anaemia, fever or infection, abnormal bleeding or bruising</li><li>convulsions (fits)</li><li>blood in the stools which may be accompanied by abdominal pain</li><li>blistering of the skin</li><li>mouth ulcers</li><li>sore throat</li><li>significant weight loss</li><li>dizziness</li><li>numbness or pins and needles</li><li>changes or loss of your tendon reflexes tested by tapping your tendon</li><li>mental depression</li><li>stomach cramps, pain in the abdomen, constipation or diarrhoea</li><li>nausea or vomiting</li><li>loss of appetite &nbsp;</li><li>pain where the tumour is</li><li>pain in your bones or muscles or jaw</li><li>headache</li><li>deafness or hearing difficulty which may be temporary or permanent hearing difficulty</li><li>problems with your balance</li><li>uncontrolled movements of the eyes, usually from side to side</li><li>heart attack or stroke</li><li>high blood pressure</li><li>shortness of breath</li><li>weakness</li><li>tiredness and generally feeling unwell</li><li>hair loss</li><li>a reduction in the production of semen</li></ul><p>&nbsp;</p><p>Vinblastine sulphate may lead to changes in your blood cells. Your doctor will take blood samples to monitor for these and also to check how well your liver is working.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p>TO REPORT ANY SIDE EFFECTS:<br />Saudi Arabia &nbsp;:<br />Fax: +966112057662<br />National Pharmacovigilance Center ( NPC )<br />Call NPC at 00966 11 2038222, Exts: 2317-2356-2340<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa/<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep Vinblastine Sulphate out of the sight and reach of children.</p><p><strong>&nbsp;</strong></p><p>Do not use this medicine after the expiry date which is stated on the vial label and carton after &#39;EXP&#39;.&nbsp; The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>The vials should be stored at 2 - 8&deg;C.</p><p>&nbsp;</p><p>The vials should be kept in the outer carton in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is vinblastine sulphate. Each millilitre (ml) of solution contains 1 milligram (mg) of vinblastine sulphate.</p><p>&nbsp;</p><p>The other ingredients are sodium chloride and Water for Injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Vinblastine Sulphate Injection is a clear, colourless solution which comes in glass containers called vials. 

It may be supplied in packs containing 5 x 10 mg/10ml vial. 


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder </strong></p><p>Hospira UK Limited</p><p>Horizon</p><p>Honey Lane</p><p>Hurley</p><p>Maidenhead</p><p>SL6 6RJ</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Manufacturer </strong></p><p>Hospira Australia Pty Ltd&nbsp; MULGRAVE, Australia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                June 2016 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">سلفات فينبلاستين هو دواء مضاد للسرطان. وفي بعض الأحيان، يُطلق على العلاج باستخدام دواء مضاد للسرطان مصطلح العلاج الكيميائي للسرطان.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">يستخدم سلفات فينبلاستين المخصص للحقن أحيانًا في علاج سرطانات العقد الليمفاوية والطحال ونخاع العظم والخصيتين والمشيمة والكلى والثدي.&nbsp; ويمكن إعطاؤه بمفرده أو بالتزامن مع أدوية أخرى مضادة للسرطان.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;"><strong>يجب ألا يُحقن سلفات فينبلاستين المخصص للحقن داخل القراب (داخل العمود الفقري) أبدًا.</strong></p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>لا تستخدم سلفات فينبلاستين المخصص للحقن في الحالات التالية:</strong></p><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بالحساسية تجاه فينبلاستين أو أي من المكونات الأخرى لهذا الدواء (مدرجة في القسم 6).</p><ul><li style="direction: rtl;">إذا كنت مصابًا بعدوى بكتيرية غير متحكم بها</li><li style="direction: rtl;">إذا أظهرت فحوص الدم الخاصة بك أنه لا يوجد لديك ما يكفي من خلايا الدم البيضاء لمحاربة العدوى</li></ul><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">أبلغ طبيبك قبل استخدام هذا الدواء إذا كانت أي من الحالات المذكورة أعلاه تنطبق عليك.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>تحذيرات واحتياطات</strong></p><p style="direction: rtl;">استشر طبيبك أو الممرضة قبل استخدام سلفات فينبلاستين المخصص للحقن</p><ul><li style="direction: rtl;">إذا كنت مريضًا مسنًّا وصحتك معتلة أو تعاني من تقرحات جلدية</li><li style="direction: rtl;">إذا كنت مصابًا بمرض في الكبد، بما في ذلك التهاب الكبد (التهاب الكبد الوبائي) أو اصفرار لون جلدك أو بياض عينيك (اليرقان).</li></ul><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">إذا لاحظت أيًا من الأعراض التالية، وكانت لا تزول، فهذا قد يعني أيضًا أنك تعاني من مشكلات في الكبد:</p><p style="direction: rtl;">&bull; فقدان الشهية.</p><p style="direction: rtl;">&bull; الشعور بالحكة.</p><p style="direction: rtl;">&bull; الشعور بالتعب وبانعدام الطاقة أو الشعور كما لو كنت مصابًا بالإنفلونزا.</p><p style="direction: rtl;">&bull; الشعور كما لو أنك على وشك التقيؤ أو التقيؤ بالفعل.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">راجع طبيبك إذا لم تكن متأكدًا.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">أبلغ طبيبك قبل استخدام هذا الدواء إذا كانت أي من الحالات المذكورة أعلاه تنطبق عليك.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الأدوية الأخرى وسلفات فينبلاستين المخصص للحقن</strong></p><p style="direction: rtl;">يجب توخي الحذر بشكل خاص إذا كنت تتناول/تستخدم أدوية أخرى نظرًا لأن بعض تلك الأدوية يمكن أن تتفاعل مع سلفات فينبلاستين، على سبيل المثال:</p><ul><li style="direction: rtl;">يمكن أن يتسبب استخدام ميتومايسين-سي و/أو بروجيستيرون (أدوية مضادة للسرطان) بالتزامن مع فينبلاستين في حدوث مشكلات في التنفس</li><li style="direction: rtl;">يمكن أن يتسبب استخدام بليومايسين أو سيسبلاتين (أدوية مضادة للسرطان) بالتزامن مع فينبلاستين في حدوث مشكلات في القلب والدورة الدموية (مثل ظاهرة رينو)</li><li style="direction: rtl;">يمكن أن يتسبب استخدام إريثرومايسين (مضاد حيوي) في زيادة الآثار الجانبية لفينبلاستين</li><li style="direction: rtl;">يمكن أن يقلل فينبلاستين من فعالية الأدوية المستخدمة لعلاج الصرع</li><li style="direction: rtl;">إذا كنت تخضع لعلاج بالإشعاع في منطقة الكبد، فسيقوم طبيبك بتأجيل إعطائك فينبلاستين</li></ul><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">أخبر طبيبك إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">أخبري طبيبكِ إذا كنتِ حاملًا أو تحاولين الحمل أو ترضعين رضاعة طبيعية. وسيقرر طبيبكِ إذا كان ينبغي أن تتلقي هذا الدواء أم لا.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">نظرًا لوجود خطر حدوث عيوب ولادية، ينبغي على السيدات القادرات على الإنجاب أن يستخدمن وسائل مناسبة لمنع الحمل أثناء العلاج بسلفات فينبلاستين.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">إذا كنتِ حاملًا أو ترضعين رضاعة طبيعية، أو تعتقدين أنكِ قد تكونين حاملًا أو تخططين للحمل، فاستشيري طبيبكِ أو الصيدلي قبل استخدام هذا الدواء.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>القيادة واستخدام الآلات</strong></p><p style="direction: rtl;">لا تقم بالقيادة أو استخدام الآلات إذا أصبت بأي آثار جانبية قد تحد من قدرتك على فعل ذلك.</p><p style="direction: rtl;"><strong>&nbsp;</strong></p><p style="direction: rtl;"><strong>يحتوي سلفات فينبلاستين المخصص للحقن على الصوديوم</strong></p><p style="direction: rtl;">يحتوي هذا المنتج الدوائي على 1.5 مللي مول من الصوديوم (35 مغ) لكل قارورة. ويجب وضع ذلك في الحسبان من قِبل المرضى الذين يتبعون نظامًا غذائيًا محدود الصوديوم.</p><p style="direction: rtl;"><strong>&nbsp;</strong></p><p style="direction: rtl;">تحتوي سدادة القارورة على مطاط طبيعي جاف (مشتق من اللاتكس)، وهو يمكن أن يتسبب في حدوث تفاعلات حساسية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">يُعطى هذا الدواء عن طريق الحقن (باستخدام محقنة) في أحد الأوردة.&nbsp; وبدلًا من ذلك، يمكن أن يُحقن داخل خط تسريب (تنقيط) متدفق.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">يُعتبر سلفات فينبلاستين مادة مهيجة، ولذلك إذا دخل إلى عينيك عن طريق الخطأ يجب عليك إبلاغ طبيبك أو الممرضة بذلك على الفور حتى يتم غسله.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">قد يتم إعطاؤك أدوية لمنع الغثيان والقيء أثناء العلاج بسلفات فينبلاستين.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الجرعة</strong></p><p style="direction: rtl;">سيحدد طبيبك مقدار الجرعة الصحيحة لك من سلفات فينبلاستين، وكذلك المعدل الواجب إعطاؤك الدواء وفقًا له.&nbsp;</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">وسيعتمد مقدار الجرعة على حالتك الطبية وحجمك ومدى كفاءة عمل كبدك. سيتمكن طبيبك من معرفة مدى كفاءة عمل كبدك باستخدام عينة دم يتم سحبها منك.&nbsp; ويمكن أن يتم تقليل الجرعة إذا لم يكن كبدك يعمل كما ينبغي.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">عادةً ما يُعطى سلفات فينبلاستين بمعدل مرة واحدة أسبوعيًا أو أقل.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>في حالة إعطاؤك كمية أكبر أو أقل مما ينبغي من سلفات فينبلاستين المخصص للحقن</strong></p><p style="direction: rtl;">سيتم إعطاء هذا الدواء لك في مستشفى، وتحت إشراف طبيب.&nbsp; ومن غير المرجح أن يتم إعطاؤك كمية أكبر أو أقل مما ينبغي، ومع ذلك، أخبر طبيبك أو الممرضة إذا كانت لديك أي مخاوف.</p><p style="direction: rtl;"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">كما هو الحال بالنسبة لجميع الأدوية، يمكن أن تكون لهذا الدواء آثار جانبية، إلا أنها لا تصيب الجميع.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>إذا حدث أي مما يلي، فأخبر طبيبك على الفور:</strong></p><ul><li style="direction: rtl;">تفاعل حساسية شديد - قد تصاب بطفح جلدي مفاجئ مثير للحكة وتورم في اليدين أو القدمين أو الكاحلين أو الوجه أو الشفتين أو الفم أو الحلق (مما قد يسبب صعوبة في البلع أو التنفس) وقد تشعر بأنك على وشك الإصابة بالإغماء.</li></ul><p style="direction: rtl;">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم أو تورم في موضع الحقن، أثناء الحقن أو بعده مباشرة</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">تُعد هذه الآثار الجانبية خطيرة. وقد تحتاج إلى عناية طبية عاجلة في حال حدوثها.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>إذا حدث أي مما يلي، فأخبر طبيبك في أسرع وقت ممكن:</strong></p><ul><li style="direction: rtl;">انخفاض تعداد خلايا الدم الذي قد يكون موجودًا في صورة فقر الدم أو الحمى أو العدوى أو النزيف غير الطبيعي أو التكدم</li><li style="direction: rtl;">التشنجات (النوبات)</li><li style="direction: rtl;">وجود دم في البراز قد يكون مصحوبًا بألم في البطن</li><li style="direction: rtl;">تبثر الجلد</li><li style="direction: rtl;">قرح الفم</li><li style="direction: rtl;">التهاب الحلق</li><li style="direction: rtl;">فقدان الوزن بشكل ملحوظ</li><li style="direction: rtl;">الدوار</li><li style="direction: rtl;">الخدر أو الإحساس بالشكشكة والوخز</li><li style="direction: rtl;">تغيرات في المنعكسات الوترية أو فقدانها، ويتم اختبار ذلك عن طريق النقر على أوتارك</li><li style="direction: rtl;">الاكتئاب العقلي</li><li style="direction: rtl;">تقلصات المعدة أو ألم في البطن أو إمساك أو إسهال</li><li style="direction: rtl;">الغثيان أو القيء</li><li style="direction: rtl;">فقدان الشهية&nbsp;</li><li style="direction: rtl;">ألم في مكان الورم</li><li style="direction: rtl;">ألم في عظامك أو عضلاتك أو فكك</li><li style="direction: rtl;">الصداع</li><li style="direction: rtl;">الصمم أو صعوبة السمع التي قد تكون مؤقتة أو دائمة</li><li style="direction: rtl;">مشكلات في التوازن</li><li style="direction: rtl;">حركات لا يمكن التحكم بها للعينين، وعادةً ما تكون من جانب إلى آخر</li><li style="direction: rtl;">الأزمة القلبية أو السكتة الدماغية</li><li style="direction: rtl;">ارتفاع ضغط الدم</li><li style="direction: rtl;">ضيق التنفس</li><li style="direction: rtl;">الضعف</li><li style="direction: rtl;">التعب وشعور عام بالتوعك</li><li style="direction: rtl;">فقدان الشعر</li><li style="direction: rtl;">انخفاض إنتاج السائل المنوي</li></ul><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">يمكن أن يتسبب سلفات فينبلاستين في حدوث تغيرات في خلايا دمك. سيقوم طبيبك بسحب عينات دم منك لرصد هذه التغيرات، وكذلك للتحقق من مدى كفاءة عمل كبدك.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p style="direction: rtl;">إذا أصبت بأي آثار جانبية، فتحدث إلى طبيبك أو الصيدلي بشأنها. يشمل هذا أي آثار جانبية محتملة غير مدرجة في هذه النشرة. بالإبلاغ عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p style="direction: rtl;">للإبلاغ عن أي آثار جانبية:</p><p>&nbsp;</p><div style="direction: rtl;"><span style="text-align:unset">المملكة العربية السعودية :</span></div><div style="direction: rtl;"><span style="text-align:unset">الفاكس: 00966112057662</span></div><div style="direction: rtl;"><span style="text-align:unset">المركز الوطني للتيقظ الدوائي ( NPC )</span></div><div style="direction: rtl;"><span style="text-align:unset">رقم الهاتف رقم: 00966112038222 تحويلة: 2317-2356-2340</span></div><div style="direction: rtl;"><span style="text-align:unset">الرقم المجاني: 19999</span></div><p>&nbsp;</p><div style="direction: rtl;"><span style="text-align:unset">البريد الإلكتروني: npc.drug@sfda.gov.sa</span></div><div style="direction: rtl;"><span style="text-align:unset">الموقع الإلكتروني: https://ade.sfda.gov.sa/</span></div><div style="direction: rtl;">&nbsp;</div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">احفظ سلفات فينبلاستين بعيدًا عن مرأى ومتناول الأطفال.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على ملصق القارورة والعبوة الكرتونية بعد الرمز &quot;EXP&quot;.&nbsp; يشير تاريخ انتهاء الصلاحية إلى آخر يوم في الشهر المذكور.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">ينبغي تخزين القوارير في درجة حرارة تتراوح بين 2-8 درجات مئوية.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">ينبغي حفظ القوارير في العبوة الكرتونية الخارجية من أجل حمايتها من الضوء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;">المادة الفعالة هي سلفات فينبلاستين. يحتوي كل ملليلتر (مل) من المحلول على 1 مليغرام (مغ) من سلفات فينبلاستين.</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">المكونات الأخرى هي كلوريد الصوديوم وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            سلفات فينبلاستين المخصص للحقن هو محلول صاف عديم اللون يأتي في حاويات زجاجية تُسمى قوارير. 

ويمكن أن يتم توفيره في عبوات تحتوي على5  قارورات x‏ 10 مغ/10 مل. 


        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p style="direction: rtl;"><strong>مالك تصريح التسويق </strong></p><p style="direction: rtl;">Hospira UK Limited</p><p style="direction: rtl;">Horizon</p><p style="direction: rtl;">Honey Lane</p><p style="direction: rtl;">Hurley</p><p style="direction: rtl;">Maidenhead</p><p style="direction: rtl;">SL6 6RJ</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;"><strong>الجهة المصنعة </strong></p><p style="direction: rtl;">&nbsp;</p><p style="direction: rtl;">Hopira Australia Pty Ltd MULGRAVE, Australia</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يونيو/حزيران 2016 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Vinblastine Sulphate 1 mg/ml Injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 1 ml contains 1.0 mg of vinblastine sulphate.
	
	Each 10 ml presentation contains 10 mg of vinblastine sulphate.

	For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for Injection

A clear, colourless sterile solution.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vinblastine sulphate is a cytotoxic drug that arrests cell growth at the metaphase.&nbsp; Its actions are more pronounced on the rapidly dividing cell than on the normal cell.&nbsp; It appears to act, like vincristine, by binding to the microtubular proteins of the mitotic spindle, preventing polymerisation.</p><p><strong>&nbsp;</strong></p><p>Information available at present suggests that vinblastine sulphate may be useful, either alone or in combination with other oncolytic drugs, for the treatment of: Hodgkin&rsquo;s disease; non-Hodgkin&rsquo;s lymphoma; carcinoma of the breast;&nbsp; methotrexate-resistant choriocarcinoma; renal cell carcinoma; testicular teratoma and seminoma; histiocytosis X. Other neoplasms occasionally show a marked response to vinblastine sulphate, but less frequently than the more susceptible conditions listed above.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Method of administration</strong></p><p>The solution may be injected either directly into the vein or into the injection site of a running intravenous infusion.&nbsp; Injection of vinblastine sulphate may be completed in about one minute.</p><p><strong>&nbsp;</strong></p><p><strong>For intravenous use only.</strong></p><p><strong>Fatal if given by other routes</strong> (see Warnings)</p><p>&nbsp;</p><p><strong>In case of mistaken administration by intrathecal route, see section 4.4.</strong></p><p>&nbsp;</p><p>Syringes containing this product should be overlabelled with the intrathecal warning label provided - <strong>&#39;FOR INTRAVENOUS USE ONLY.&nbsp; FATAL IF GIVEN BY OTHER ROUTES&#39;.</strong></p><p><strong>&nbsp;</strong></p><p>Posology</p><p><strong>&nbsp;</strong></p><p>The recommended dose for adults, the elderly and children is 6 mg/m<sup>2</sup>, usually administered no more frequently than once every seven days.&nbsp; For testicular tumours, the dosage may be increased to 0.2 mg/kg administered on each of two consecutive days every three weeks.</p><p><strong>&nbsp;</strong></p><p>To minimise the possibility of extravascular spillage, it is suggested that the syringe and needle be rinsed with venous blood before withdrawal. The dose should not be diluted in large volumes of diluent (ie, 100 to 250 ml) or given intravenously for prolonged periods (ranging from 30 to 60 minutes or more), since this frequently results in irritation of the vein and increases the chance of extravasation.</p><p>&nbsp;</p><p>Because of the enhanced possibility of thrombosis, it is considered inadvisable to inject a solution of vinblastine sulphate into an extremity in which the circulation is impaired, or potentially impaired, by such conditions as compressing or invading neoplasm, phlebitis or varicosity.</p><p>&nbsp;</p><p><strong>Patients with hepatic impairment</strong></p><p>&nbsp;</p><p>As vinblastine is excreted principally by the liver, toxicity may be increased when there is hepatic insufficiency and it may be necessary to reduce initial doses in the presence of significantly impaired hepatic or biliary function. A reduction of 50% in the dose is recommended for patients having a direct serum bilirubin value above 3&nbsp;mg/100 ml.</p><p>&nbsp;</p><p><strong>Patients with renal impairment</strong></p><p>&nbsp;</p><p>Since metabolism and excretion are primarily hepatic, no modification is recommended for patients with impaired renal function.</p><p><strong>&nbsp;</strong></p><p><strong>Vinblastine should not be given intramuscularly, subcutaneously or intrathecally.</strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

For intravenous use only.  Fatal if given by other routes (see Warnings).

Vinblastine sulphate is contraindicated in patients who are leucopenic.  It should not be used in the presence of bacterial infection.  Such infections should be brought under control with antiseptics or antibiotics before the initiation of therapy with vinblastine sulphate.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Warnings:</strong>&nbsp; Vinblastine sulphate must be used only by physicians experienced in cytotoxic chemotherapy.</p><p>&nbsp;</p><p>The following treatment successfully arrested progressive paralysis in a single patient mistakenly given the related vincristine sulphate, intrathecally.&nbsp; This treatment should be initiated immediately:</p><p>&nbsp;</p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Removal of as much CSF as is safely possible.</p><p>&nbsp;</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flushing with Lactated Ringer&#39;s solution by continuous infusion at 150 ml/h, through a catheter in a cerebral lateral ventricle and removed through lumbar access, until fresh plasma became available.</p><p>&nbsp;</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fresh frozen plasma, 25 ml, diluted with 1litre of Lactated Ringer&#39;s was then infused similarly at 75 ml/h.&nbsp; The rate of infusion should be adjusted to maintain a spinal fluid protein level of 150 mg/dl.</p><p>&nbsp;</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Glutamic acid, 10 g, was given iv over 24 hours, followed by 500 mg tds by mouth for 1 month.&nbsp; Glutamic acid may not be essential.</p><p>&nbsp;</p><p><strong>Vinblastine should not be given intramuscularly, subcutaneously or intrathecally.</strong></p><p><strong>&nbsp;</strong></p><p>Syringes containing this product should be overlabelled with the intrathecal warning label provided - <strong>&#39;FOR INTRAVENOUS USE ONLY.&nbsp; FATAL IF GIVEN BY OTHER ROUTES&#39;.</strong></p><p><strong>&nbsp;</strong></p><p>Caution is necessary with the use of vinblastine sulphate during pregnancy. There is insufficient information to assess vinblastine sulphate&rsquo;s effect on fertility in men and women.&nbsp; However, aspermia has been reported in man.</p><p>&nbsp;</p><p>Animal studies suggest that teratogenic effects may occur.&nbsp; The drug should not be used in pregnant women unless the expected benefit outweighs the potential risk.</p><p><strong>&nbsp;</strong></p><p>As with other antineoplastic agents, vinblastine may cause a severe local reaction on extravasation.&nbsp; If leakage into the surrounding tissue should occur during intravenous administration of vinblastine sulphate, the injection should be discontinued immediately and any remaining portion of the dose should be introduced into another vein.&nbsp; Local injection of hyaluronidase with the application of heat has been used to disperse the drug in order to minimise discomfort and the possibility of tissue damage.</p><p>&nbsp;</p><p>Liver disease may alter the elimination of vinblastine in the bile, markedly increasing toxicity to peripheral nerves and necessitating a dosage modification in affected patients.</p><p>&nbsp;</p><p>The vial stopper contains dry natural rubber (a derivative of latex), which may cause allergic reactions.&nbsp;</p><p>&nbsp;</p><p><strong>Precautions:</strong>&nbsp; Patients should be carefully monitored for infection until the white cell count has returned to normal levels, if leucopenia with less than 2000 white blood cells per mm<sup>3</sup> occurs following a dose of vinblastine sulphate.</p><p>&nbsp;</p><p>When cachexia or ulcerated areas of the skin are present, a more profound leucopenic response may be produced by vinblastine.&nbsp; Therefore, its use should be avoided in older persons suffering from either of these conditions.</p><p>&nbsp;</p><p>Leucocyte and platelet counts have sometimes fallen precipitously after moderate doses of vinblastine sulphate in patients with malignant cell infiltration of the bone marrow.&nbsp;</p><p>&nbsp;</p><p>Further use of the drug in such patients is inadvisable.&nbsp; Avoid contamination of the eye with vinblastine sulphate injection.&nbsp; If accidental contamination occurs, severe irritation or corneal ulceration may result.&nbsp; The affected eye should be thoroughly irrigated with water immediately.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When chemotherapy is being given in conjunction with radiation therapy through portals which include the liver, the use of vinblastine should be delayed until radiation therapy has been completed.</p><p>&nbsp;</p><p>ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vinblastine used as part of a combination regimen with mitomycin may result in acute respiratory distress and pulmonary infiltration. Cases of respiratory distress with interstitial pulmonary infiltrates have been reported in patients given a regimen comprising vinblastine, mitomycin, and progesterone (MVP). Acute shortness of breath and severe bronchospasm have been reported following the administration of the vinca alkaloids. These reactions have been encountered most frequently when the vinca alkaloid was used in combination with mitomycin-C and may be serious when there is pre-existing pulmonary dysfunction. The onset may be within minutes, or several hours after the vinca is injected, and may occur up to 2 weeks following a dose of mitomycin. Progressive dyspnoea, requiring chronic therapy, may occur. Vinblastine should not be re-administered.</p><p>&nbsp;</p><p>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Co-administration of cisplatin has been reported to cause higher plasma concentrations of vinblastine.</p><p><strong>&nbsp;</strong></p><p>(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There have been reports of Raynaud&rsquo;s phenomenon and gangrene following co-administration of vinblastine and bleomycin, and of other vascular events (such as myocardial infarction and cerebrovascular accident) following combined treatment with vinblastine, bleomycin and cisplatin.</p><p><strong>&nbsp;</strong></p><p>(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erythromycin may increase the toxicity of vinblastine.</p><p>&nbsp;</p><p>(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serum levels of anticonvulsants may be reduced by cytotoxic drug regimes, which include vinblastine.</p><p>&nbsp;</p><p>(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Caution should be exercised in patients concurrently taking drugs known to inhibit drug metabolism by hepatic cytochrome P450 isoenzymes in the CYP 3A subfamily, or in patients with hepatic dysfunction. Concurrent administration of vinblastine sulphate with an inhibitor of this metabolic pathway may cause an earlier onset and/or an increased severity of side-effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Although information on the use of vinblastine during pregnancy is limited, the drug may cause foetal toxicity when administered to pregnant women.&nbsp; The drug causes resorption of foetuses in animals and produces gross foetal abnormalities in surviving offspring.&nbsp; There are no adequate and controlled studies to date using vinblastine in pregnant women, and the drug should be used during pregnancy only in life-threatening situations or severe disease for which safer drugs cannot be used or are ineffective.&nbsp; Women of childbearing potential should be advised to avoid becoming pregnant while receiving the drug.&nbsp; When vinblastine is administered during pregnancy or the patient becomes pregnant while receiving the drug, the patient should be informed of the potential hazard to the foetus.</p><p>&nbsp;</p><p>The effect of vinblastine on fertility in humans is not fully known. &nbsp;Aspermia has occurred in some individuals during vinblastine therapy.</p><p>&nbsp;</p><p>It is not known whether vinblastine is excreted in human milk.&nbsp; Because of the potential for serious adverse reactions due to vinblastine in nursing infants, a decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The use of small amounts of vinblastine daily for long periods is not advisable, even though the resulting total dosage may be similar to the recommended dosage. Little or no therapeutic advantage has been demonstrated when such regimens have been used and side-effects are increased.</p><p>&nbsp;</p><p>The incidence of side effects with vinblastine sulphate appears to be dose related and most do not persist longer than 24 hours.&nbsp; Neurological effects are uncommon but can occur and may last longer than 24 hours.</p><p>&nbsp;</p><p>Leucopenia is the most common side effect and dose limiting factor.</p><p>&nbsp;</p><p>The following side effects have been reported:</p><p>&nbsp;</p><p><strong>Blood and lymphatic system disorders: </strong>Leucopenia, thrombocytopaenia, anaemia.</p><p><strong>&nbsp;</strong></p><p><strong>Nervous system disorders:</strong>&nbsp; numbness, paraesthesias, peripheral neuritis, mental depression, loss of deep tendon reflexes, headache, convulsions, Treatment with vinca alkaloids has resulted rarely in both vestibular and auditory damage to the eighth cranial nerve. Manifestations include partial or total deafness, which may be temporary or permanent, and difficulties with balance including dizziness, nystagmus, and vertigo. Particular caution is warranted when vinblastine sulphate is used in combination with other agents known to be ototoxic, such as the platinum-containing oncolytics.</p><p>&nbsp;</p><p><strong>Cardiac disorders:</strong> Myocardial infarction, cerebrovascular accident (cases of unexpected myocardial infarction and cerebrovascular accidents have occurred in patients undergoing combination chemotherapy with vinblastine, bleomycin and cisplatin).</p><p>&nbsp;</p><p><strong>Vascular disorders:</strong> Hypertension.</p><p>&nbsp;</p><p><strong>Respiratory, thoracic and mediastinal disorders</strong>: Acute respiratory distress (including shortness of breath) has been reported when vinblastine is given in combinations with mitomycin (see Section 4.5, Interactions with other Medicinal Products and other Forms of Interaction).</p><p>&nbsp;</p><p><strong>Gastrointestinal disorders:</strong>&nbsp; nausea, vomiting, constipation, oral mucosal blistering, diarrhoea, anorexia, abdominal pain, rectal bleeding, pharyngitis, haemorrhagic enterocolitis, bleeding <u>from</u> an old peptic ulcer, ileus, stomatitis. Antiemetics may be used to control nausea and vomiting.</p><p>&nbsp;</p><p><strong>Skin and subcutaneous tissue infections and infestations:</strong> blister (skin), alopecia (usually not total and in some cases the hair regrows during maintenance therapy).</p><p><strong>&nbsp;</strong></p><p><strong>Musculoskeletal and connective tissue disorders: Myalgia, </strong>bone pain, jaw pain, tumour pain (pain in tumour-containing tissue).</p><p><strong>&nbsp;</strong></p><p><strong>General disorders and administration site conditions:</strong>&nbsp; malaise, asthenia, dizziness.</p><p>&nbsp;</p><p><strong>Injection site reaction (see Section 4.2, Posology and Method of Administration).</strong> Extravasation during intravenous injection may result in cellulitis and phlebitis.&nbsp; In extreme instances sloughing may occur. Syndrome of inappropriate ADH secretion has been reported with higher than recommended doses. Raynaud&rsquo;s phenomenon has occurred when patients are being treated with vinblastine in combination with bleomycin and cisplatin for testicular cancer.</p><p><strong>&nbsp;</strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; <strong><u>Reporting of suspected adverse reactions</u></strong></p><p>&nbsp;</p><p>Reporting suspected adverse reactions after marketing authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions according to their local requirements.</p><p>&nbsp;</p><p>TO REPORT ANY SIDE EFFECTS:<br />Saudi Arabia &nbsp;:<br />Fax: +966112057662<br />National Pharmacovigilance Center ( NPC )<br />Call NPC at 00966 11 2038222, Exts: 2317-2356-2340<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa/<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Side effects following the use of vinblastine are dose related.&nbsp; Therefore, following administration of more than the recommended dose, patients can be expected to experience these effects in an exaggerated fashion.</p><p>&nbsp;</p><p>In addition, neurotoxicity similar to that seen with vincristine sulphate may be observed.</p><p>&nbsp;</p><p><strong>Treatment:</strong>&nbsp; Supportive care should include:&nbsp; (1) prevention of the side effects that result from the syndrome of inappropriate secretion of antidiuretic hormone.&nbsp; This includes restriction of fluid intake and perhaps the use of a diuretic acting on the loop of Henle and distal tubule function; (2) administration of an anticonvulsant; (3) prevention and treatment of ileus; (4) monitoring the patient&#39;s cardiovascular system; and (5) daily blood counts for guidance in transfusion requirement.</p><p>&nbsp;</p><p>The major effect of excessive doses of vinblastine will be on granulocytopoeisis, and this may be life-threatening.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Although the mechanism of action has not been definitely established, vinblastine appears to bind to or crystallise critical microtubular proteins of the mitotic spindle, thus preventing their proper polymerisation and causing metaphase arrest.&nbsp; In high concentrations, vinblastine also exerts complex effects on nucleic acid and protein synthesis.&nbsp; Vinblastine reportedly also interferes with amino acid metabolism by blocking cellular utilisation of glutamic acid and thus inhibits purine synthesis, the citric acid cycle, and the formation of urea.&nbsp; Vinblastine exerts some immunosuppressive activity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vinblastine sulphate is unpredictably absorbed from the GI tract.&nbsp; Following intravenous administration, the drug is rapidly cleared from the blood and distributed into body tissues.</p><p>&nbsp;</p><p>Vinblastine crosses the blood-brain barrier poorly and does not appear in the CSF in therapeutic concentrations.&nbsp; Vinblastine is reported to be extensively metabolised, primarily in the liver, to desacetylvinblastine, which is more active than the parent compound on a weight basis.&nbsp; The drug is excreted slowly in urine and in faeces via the bile.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not available</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium Chloride</p><p>Water for Injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vinblastine sulphate is incompatible with furosemide, when injected sequentially into Y-site with no flush between or when mixed in syringe.&nbsp; Immediate precipitation results.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Do not use Vincristine sulphate after the expiry date which is stated on the Vial label after     EXP: The expiry date refers to the last day of that month.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store at 2 - 8&deg;C.&nbsp; Keep container in outer carton to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>10 ml, Type I clear conventional glass vial, West Type 1888 rubber closure, aluminium spun cap ring, in packs of 5 vials.</p><p>&nbsp;</p><p>Also, 10 ml, Type I clear Onco-Tain<sup>&reg;</sup> vials, West Type 1888 rubber closure, aluminium spun cap ring, in packs of 5 vials.</p><p>&nbsp;</p><p>Not all above presentations and pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Cytotoxic Handling Guidelines</strong></p><p>&nbsp;</p><p><strong>Administration</strong></p><p>&nbsp;</p><p>Should be administered only by or under the direct supervision of a qualified physician who is experienced in the use of cancer chemotherapeutic agents.</p><p>&nbsp;</p><p><strong>Preparation (Guidelines)</strong></p><p>&nbsp;</p><p>a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chemotherapeutic agents should be prepared for administration only by professionals who have been trained in the safe use of the preparation.</p><p>&nbsp;</p><p>b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operations such as reconstitution of powder and transfer to syringes should be carried out only in the designated area.</p><p>&nbsp;</p><p>c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The personnel carrying out these procedures should be adequately protected with clothing, gloves and eye shield.</p><p>&nbsp;</p><p>d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pregnant personnel are advised not to handle chemotherapeutic agents.</p><p>&nbsp;</p><p><strong>Contamination</strong></p><p>&nbsp;</p><p>a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the event of contact with the skin or eyes, the affected area should be washed with copious amounts of water or normal saline.&nbsp; A bland cream may be used to treat the transient stinging of skin.&nbsp; Medical advice should be sought if the eyes are affected.</p><p>&nbsp;</p><p>b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the event of spillage, operators should put on gloves and mop up the spilled material with a sponge kept in the area for that purpose.&nbsp; Rinse the area twice with water.&nbsp; Put all solutions and sponges into a plastic bag and seal it.</p><p>&nbsp;</p><p><strong>Disposal</strong></p><p>&nbsp;</p><p>Syringes, containers, absorbent materials, solution and any other contaminated material should be placed in a thick plastic bag or other impervious container and incinerated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MARKETING AUTHORISATION HOLDER

		
Hospira UK Limited
Horizon
Honey Lane
Hurley 
Maidenhead
SL6 6RJ, UK

MANUFACTURER 


Hospira Australia Pty Ltd  MULGRAVE, Australia

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                June 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>